Evogene Ltd.
EVGN
$0.60
$0.000.39%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | 28.26% | 29.16% | 30.96% | 34.62% |
| Total Depreciation and Amortization | -- | -39.17% | -61.39% | -47.13% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -706.48% | -520.15% | -2,828.89% | -60.28% |
| Change in Net Operating Assets | -- | 46.80% | -24.21% | -553.25% | 64.97% |
| Cash from Operations | -- | 11.04% | -6.85% | 8.69% | 39.30% |
| Capital Expenditure | -- | -24.36% | -6.70% | 20.38% | 27.11% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | -61.54% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 235.15% | 240.45% | 370.92% | -120.79% |
| Cash from Investing | -- | 285.15% | 225.38% | 312.05% | -127.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 21.72% | 6.97% | -5.98% | -67.09% |
| Issuance of Common Stock | -- | 19.77% | -31.33% | -33.45% | 56,066.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 125.58% | -99.56% | -100.76% | 4.85% |
| Cash from Financing | -- | 28.47% | -72.56% | -74.34% | 86.98% |
| Foreign Exchange rate Adjustments | -- | 61.11% | 70.00% | 80.00% | 89.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 89.25% | 60.13% | 33.35% | 21.55% |